Decreased FOXP3 levels in multiple sclerosis patients

Journal of Neuroscience Research

Volumn 81, Issue 1, 2005, Pages 45-52

  Huan, Jianya ^a   Culbertson, Nicole ^a,b   Spencer, Leslie ^a,b   Bartholomew, Richard ^c   Burrows, Gregory G ^a,b   Chou, Yuan K ^a,b   Bourdette, Dennis ^a   Ziegler, Steven F ^d   Offner, Halina ^a,b   Vandenbark, Arthur A ^a,b,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Orchestra Therapeutics Inc   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

^e PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

FOXP3; Multiple sclerosis; Treg cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC MARKER; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MALE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 23744515175     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20522     Document Type: Article

References (32)

1. + T cells in the thymus of patients with autoimmune myasthenia gravis. Blood Online1-32.
2. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20-21.
3. Bluestone JA, Abbas AK. 2003. Natural versus adaptive regulatory T cells. Nat Rev Immunol 3:253-257.
4. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27:68-73.
5. + T cells for self-T cell receptor determinants. J Neurosci Res 76:129-140.
6. Coffer PJ, Burgering BMT. 2004. Forkhead-box transcription factors and their role in the immune system. Nat Rev 4:889-899.
7. + regulatory T cells by peripheral expansion. J Immunol 173:7259-7268.
8. + regulatory T cells. Nat Immunol 4:330-336.
9. Gambineri E, Torgerson TR, Ochs HD. 2003. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15:430-435.
10. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. 2004. Human T regulatory cells can use the perform pathway to cause autologous target cell death. Immunity 21:589-601.
11. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199:1479-1489.
12. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061.
13. +T regulatory cells. Nat Immunol 4:337-342.
14. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169:4712-4716.
15. + regulatory T-cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285-1291.
16. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N. 2002. Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 109:131-140.
17. Kumar V. 2004. Homeostatic control of immunity by TCR peptide-specific Tregs. J Clin Invest 114:1222-1226.
18. + T-cells from patients with type 1 diabetes. Diabetes 54:92-99.
19. Maloy KJ, Powrie F. 2001. Regulatory T cells in the control of immune pathology. Nat Immunol 2:816-822.
20. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A 101:4572-4577.
21. + regulatory T cell compartment. J Immunol 173:2227-2230.
22. Putheti P, Morris M, Stawiarz L, Teleshova N, Kivisakk P, Pashenkov M, Kouwenhoven M, Wiberg MK, Bronge L, Huang YM, Soderstrom M, Hillert J, Link H. 2003. Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables. Eur J Neurol 10:525-535.
23. + T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J Clin Immunol 24:155-161.
24. Ramsdell F. 2003. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19:165-168.
25. Sakaguchi S. 2000. Regulatory T cells: key controllers of immunological self-tolerance. Cell 101:455-458.
26. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164.
27. Shevach EM. 2000. Regulatory T cells in autoimmunity. Annu Rev Immunol 18:423-449.
28. Tai X, Cowan M, Feigenbaum L, Singer A. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol Online, 9 January, p 1-11.
29. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971-979.
30. + regulatory T cells in vivo. J Exp Med 198:249-258.
31. - T cells. J Clin Invest 112:1437-1443.
32. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20.